glp 1 agonist function GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Science Behind GLP 1 GIP
Description
A novel mouse model of glucagon-like peptide-1 receptor expression: a look at the brain
In recent years, select drugs in the glucagon-like peptide-1 (GLP-1) class have been FDA approved for weight loss
Evidence-based guidelines meet the real world: the case of diabetes care
GLP-1 RAs, in contrast, exert their effects systemically by reducing central adiposity, improving insulin sensitivity, and modulating autonomic tone and inflammation, key pathophysiologic drivers of OSA [1, 2]
